Skip to main content
. 2015 Apr 8;21:2. doi: 10.1186/s40885-014-0013-2

Figure 3.

Figure 3

Recommended combination therapy, thick lines; preferred combination, thin line; feasible combination. ARB angiotensin receptor blocker, ACE angiotensin-converting enzyme.